CCL Products Q2 FY27 results - revenue up 22.5%, consol PAT up 29%

Revenue Growth 20pctPat Growth 25pctResults View source PDF Explain this filing

CCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-7.5%Reaction day

₹1091.50

prior close

₹1042.10

announcement price

After-mkt

timing

Nifty Smallcap 250market+0.1%-7.5% vs market

Tea & Coffee peers, median of 22sector+0.1%-7.6% vs sector

On the reaction day the stock moved 7.5 pts less than Nifty Smallcap 250 and 7.6 pts less than its Tea & Coffee peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.4

10m

-3.1

15m

-2.6

30m

-3.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-7.5+0.1-7.5+0.1-7.6

Next day

-10.1-1.1-9.0-0.7-9.4

-11.6-3.3-8.3-2.6-9.0

-15.0-4.4-10.6-3.6-11.4

-17.3-7.0-10.2-4.4-12.8

-17.8-6.0-11.8-5.5-12.3

-14.0-3.6-10.4-3.8-10.2

15d

—————

UpDownMarket · Nifty Smallcap 250Sector · Tea & Coffee peers, median of 22Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q2 FY27: Standalone revenue up 22.5 percent YoY at Rs 685.05 cr but standalone PAT fell 61.6 percent to Rs 43.06 cr as prior year had Rs 70.42 cr one-time income from Vietnam subsidiary. Consolidated revenue up 7.5 percent at Rs 1,210.76 cr, PAT up 29 percent at Rs 130.09 cr. H1 consolidated PAT up 42.5 percent. Statutory auditors issued unmodified review report. Company Secretary change also announced.

Likely market impact

Mixed picture: strong consolidated PAT growth on operating basis, but standalone PAT decline is due to a base effect (one-time income last year), not core weakness. No audit concerns.